By contrast, a tumor-promoting effect of DPP-IV was suggested in pleural mesothelioma, where DPP-IV is expressed in cancer stem cells and might serve as a promising therapeutic target [59]. The gene discussed is FAP; the disease is pleural mesothelioma.